Tamiflu News
Most Popular Tamiflu Story
Roche results spotlight targeted-drug strategy
After a series of Big Pharma letdowns, Roche's ($RHHBY) results announcement was a series of positives: An increase in 2011 net income, a sales-growth forecast in the "low to mid-single digits," and Read more...
Latest Headlines
- February 1, 2012
- January 18, 2012
- October 14, 2010
- December 9, 2009
- November 23, 2009
- October 15, 2009
- October 5, 2009
- September 8, 2009
- August 14, 2009
- August 10, 2009
- August 4, 2009
- July 13, 2009
- June 30, 2009
- May 14, 2009
- May 13, 2009
- May 4, 2009
- May 4, 2009
- April 27, 2009
- April 27, 2009
- April 27, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
